Campbell & Co Investment Adviser’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,471
Closed -$2.5M 1267
2025
Q3
$2.5M Sell
13,471
-13,995
-51% -$2.4M 0.19% 126
2025
Q2
$4.2M Buy
27,466
+25,296
+1,166% +$3.89M 0.26% 66
2025
Q1
$360K Sell
2,170
-42,325
-95% -$6.62M 0.03% 794
2024
Q4
$6.43M Buy
44,495
+42,040
+1,712% +$6.51M 0.5% 19
2024
Q3
$398K Sell
2,455
-4,993
-67% -$796K 0.03% 804
2024
Q2
$1.09M Buy
+7,448
New +$1.11M 0.09% 331
2020
Q3
Sell
-2,132
Closed -$300K 433
2020
Q2
$300K Buy
+2,132
New +$311K 0.38% 105
2019
Q4
Sell
-2,267
Closed -$293K 738
2019
Q3
$293K Buy
+2,267
New +$299K 0.11% 396
2018
Q3
Sell
-3,100
Closed -$376K 451
2018
Q2
$376K Buy
+3,100
New +$387K 0.29% 125
2014
Q1
Sell
-18,881
Closed -$1.73M 250
2013
Q4
$1.73M Buy
+18,881
New +$1.74M 0.39% 94

Other funds holding JNJ

Campbell & Co Investment Adviser's JNJ Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 13,471 shares — an estimated $2.5M sold.

Campbell & Co Investment Adviser first reported a position in JNJ in Q4 2013 and held it in 10 quarters. The position peaked at $6.43M in Q4 2024. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 13,471 Johnson & Johnson shares in Q4 2025, an estimated $2.5M.
  • Campbell & Co Investment Adviser first reported a position in Johnson & Johnson in Q4 2013 and held it in 10 quarters.
  • Campbell & Co Investment Adviser's Johnson & Johnson position peaked at $6.43M in Q4 2024.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.